Literature DB >> 3221245

Specific IgG subclass reactivity in herpes simplex encephalitis.

T Mathiesen1, A Linde, E Olding-Stenkvist, B Wahren.   

Abstract

Serum and cerebrospinal fluid (CSF) samples from 19 patients with a previous diagnosis of herpes simplex virus encephalitis (HSVE), from 14 patients with a previous diagnosis of non HSVE encephalitis and from 21 healthy subjects were examined to detect IgG subclasses 1-4 reactive with herpes simplex virus (HSV), cytomegalovirus (CMV) and varicella zoster virus (VZV). Antibodies to HSV were detected in CSF and serum from the 14 HSVE-patients with a reactivated HSV infection and from 3 of the 5 patients with a primary HSV infection. The predominant subclass pattern was an early HSV-specific IgG1 rise, followed by IgG3 and, more seldom, IgG4; HSV IgG2 was rarely seen. In HSVE patients, HSV IgG3 was absent in early samples and usually appeared 10-20 days after onset of disease. In 14 out of 16 seropositive healthy controls, on the other hand, HSV IgG3 was present in the CSF. Rising VZV IgG levels in serum and CSF were found in 11 HSVE patients. Eight of them showed signs of intrathecal VZV IgG1 synthesis. The VZV IgG reactivity was restricted to IgG1 in 7 of these whereas the HSV IgG subclass response also included IgG3 or 4. The appearance of several HSV IgG subclasses appeared to serve as a marker of HSV infection in spite of the serological VZV reaction, usually restricted to VZV IgG1. Intrathecal synthesis of the quantitatively minor HSV IgG3 and 4 subclasses was detected earlier than intrathecal synthesis of total HSV IgG, dominated by IgG1 in 4 patients with HSVE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221245     DOI: 10.1007/bf00314481

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Measles IgM antibodies in cerebrospinal fluid and serum in subacute sclerosing panencephalitis.

Authors:  F Chiodi; V A Sundqvist; E Norrby; M Mavra; H Link
Journal:  J Med Virol       Date:  1986-02       Impact factor: 2.327

2.  An interchangeable ELISA for cytomegalovirus antigen and antibody.

Authors:  V A Sundqvist; B Wahren
Journal:  J Virol Methods       Date:  1981-04       Impact factor: 2.014

3.  Early diagnosis and treatment of herpes simplex encephalitis.

Authors:  K Felgenhauer; R Ackermann
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis.

Authors:  P J Johansson; J Blomberg
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

5.  Sensitive analytic ELISAs for subclass herpes virus IgG.

Authors:  G Gilljam; V A Sundqvist; A Linde; P Pihlstedt; A E Eklund; B Wahren
Journal:  J Virol Methods       Date:  1985-03       Impact factor: 2.014

6.  IgG subclass antibodies to herpes simplex virus.

Authors:  R M Coleman; A J Nahmias; S C Williams; D J Phillips; C M Black; C B Reimer
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

7.  The demonstration of locally synthesized herpes simplex IgG antibodies in CSF by a Sepharose 4B linked enzyme immunoassay.

Authors:  K Felgenhauer; M Nekic; R Ackermann
Journal:  J Neuroimmunol       Date:  1982-10       Impact factor: 3.478

8.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

9.  Subclass distribution of rubella virus-specific immunoglobulin G.

Authors:  G A Linde
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

10.  Acyclovir versus vidarabine in herpes simplex encephalitis.

Authors:  B Sköldenberg; M Forsgren
Journal:  Scand J Infect Dis Suppl       Date:  1985
View more
  4 in total

1.  Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients.

Authors:  T Mathiesen; L Hammarström; E Fridell; A Linde; G Wirsen; C I Smith; E Norrby; B Wahren
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 2.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

3.  Antiviral IgM and IgG subclasses in varicella zoster associated neurological syndromes.

Authors:  T Mathiesen; A Linde; E Olding-Stenkvist; B Wahren
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

4.  Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system.

Authors:  T Mathiesen; H von Holst; S Fredrikson; G Wirsén; B Hederstedt; E Norrby; V A Sundqvist; B Wahren
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.